Cargando…
Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain
Tau seed amplification assays (SAAs) directly measure the seeding activity of tau and would therefore be ideal biomarkers for clinical trials targeting seeding-competent tau in Alzheimer’s disease (AD). However, the precise relationship between tau seeding measured by SAA and the levels of pathologi...
Autores principales: | Frey, Bryan, Holzinger, David, Taylor, Keenan, Ehrnhoefer, Dagmar E., Striebinger, Andreas, Biesinger, Sandra, Gasparini, Laura, O’Neill, Michael J., Wegner, Florian, Barghorn, Stefan, Höglinger, Günter U., Heym, Roland G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644662/ https://www.ncbi.nlm.nih.gov/pubmed/37964332 http://dx.doi.org/10.1186/s40478-023-01676-w |
Ejemplares similares
-
Fully co-factor-free ClearTau platform produces seeding-competent Tau fibrils for reconstructing pathological Tau aggregates
por: Limorenko, Galina, et al.
Publicado: (2023) -
N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain
por: Schlegel, Kerstin, et al.
Publicado: (2019) -
Amplification of Tau Fibrils from Minute Quantities
of Seeds
por: Meyer, Virginia, et al.
Publicado: (2014) -
Biophysical properties of a tau seed
por: Hou, Zhiqiang, et al.
Publicado: (2021) -
The dual fates of exogenous tau seeds: Lysosomal clearance versus cytoplasmic amplification
por: Kolay, Sourav, et al.
Publicado: (2022)